These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 18554294)

  • 1. Neurokinin receptor modulation of respiratory activity in the rabbit.
    Bongianni F; Mutolo D; Cinelli E; Pantaleo T
    Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
    J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
    Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
    Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
    Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
    Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
    Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neuropeptides on the sumatriptan-disturbed circulation in the optic nerve head of rabbits.
    Gaspar MN; Ribeiro CA; Cunha-Vaz JG; Macedo TR
    Pharmacology; 2004 Mar; 70(3):152-9. PubMed ID: 14752235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
    Patacchini R; Barthó L; Maggi CA
    Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
    Cheng FH; Chan SW; Rudd JA
    Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurokinin-1 receptors modulate the excitability of expiratory neurons in the ventral respiratory group.
    Fong AY; Potts JT
    J Neurophysiol; 2008 Feb; 99(2):900-14. PubMed ID: 18057111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation of irregular spiking activity by multiple neurokinin-receptors in the small intestine of the rat.
    Lördal M; Bränström R; Hellström PM
    Br J Pharmacol; 1998 Jan; 123(1):63-70. PubMed ID: 9484855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
    Patacchini R; Quartara L; Astolfi M; Goso C; Giachetti A; Maggi CA
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
    Juszczak M; Boczek-Leszczyk E
    J Physiol Pharmacol; 2008 Sep; 59(3):553-62. PubMed ID: 18953097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological examination of the neurokinin-1 receptor mediating relaxation of human intralobar pulmonary artery.
    Pedersen KE; Buckner CK; Meeker SN; Undem BJ
    J Pharmacol Exp Ther; 2000 Jan; 292(1):319-25. PubMed ID: 10604965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
    Tauer U; Zhao Y; Hunt SP; Culman J
    Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of neurokinins on canine prostate cell physiology.
    Walden PD; Marinese D; Srinivasan D; Tzoumaka E; Syyong HT; Ford AP; Bhattacharya A
    Prostate; 2005 Jun; 63(4):358-68. PubMed ID: 15611996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies.
    Juszczak M; Boczek-Leszczyk E; Stempniak B
    J Physiol Pharmacol; 2007 Dec; 58(4):829-43. PubMed ID: 18195491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists.
    Mazzone SB; Geraghty DP
    Br J Pharmacol; 2000 Mar; 129(6):1121-31. PubMed ID: 10725260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous mechanisms in the generation of the pattern of breathing.
    Pantaleo T; Bongianni F; Mutolo D
    Arch Ital Biol; 2005 Sep; 143(3-4):207-14. PubMed ID: 16097497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
    Juszczak M
    Neuro Endocrinol Lett; 2005 Aug; 26(4):367-72. PubMed ID: 16136007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.